Skip to main content

Home/ Nutrition/ Group items tagged ImClone

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Erbitux Increases Overall Survival For Head And Neck Cancer Patients - 0 views

www.medicalnewstoday.com/healthnews.php

Erbitux Cetuximab Survival Head Neck Cancer HNCa SCC metastatic squamous cell carcinoma recurrent advanced ImClone EXTREME cisplatin 5-fluorouracil 5-FU carboplatin platinum news phase-III rct medicine medical science SCCHN clinical_trial

shared by Matti Narkia on 06 Aug 09 - Cached
  • Matti Narkia on 06 Aug 09
     
    Erbitux (Cetuximab), a new drug which is used in combination with chemotherapy, increases overall survival in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck, according to ImClone, the company which introduced the dr
1 - 1 of 1
Showing 20▼ items per page